See more : Matrix Composites & Engineering Ltd (MCE.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Nectar Lifesciences Limited (NECLIFE.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nectar Lifesciences Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Summit Hotel Properties, Inc. (INN) Income Statement Analysis – Financial Results
- SAMHI Hotels Limited (SAMHI.NS) Income Statement Analysis – Financial Results
- Moury Construct SA (MOUR.BR) Income Statement Analysis – Financial Results
- PT Bumi Serpong Damai Tbk (BSPDY) Income Statement Analysis – Financial Results
- AMCI Acquisition Corp. II (AMCI) Income Statement Analysis – Financial Results
Nectar Lifesciences Limited (NECLIFE.BO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.neclife.com
About Nectar Lifesciences Limited
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company's active pharmaceutical ingredients and intermediates comprise cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. It also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, the company provides menthol and mint derivatives and empty hard gelatin capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16.84B | 15.24B | 16.69B | 15.43B | 23.66B | 27.83B | 18.76B | 16.44B | 16.76B | 16.43B | 16.38B | 16.25B | 13.03B | 10.55B | 8.46B | 7.80B | 7.74B | 4.69B | 2.91B |
| Cost of Revenue | 13.87B | 13.31B | 13.70B | 12.86B | 19.98B | 23.71B | 15.11B | 12.82B | 13.00B | 12.57B | 12.53B | 12.36B | 9.77B | 7.68B | 5.79B | -73.42M | 95.27M | -137.25M | -67.70M |
| Gross Profit | 2.97B | 1.92B | 2.99B | 2.58B | 3.69B | 4.12B | 3.65B | 3.62B | 3.75B | 3.86B | 3.85B | 3.89B | 3.26B | 2.88B | 2.67B | 7.87B | 7.65B | 4.83B | 2.97B |
| Gross Profit Ratio | 17.65% | 12.62% | 17.94% | 16.69% | 15.59% | 14.81% | 19.46% | 22.01% | 22.39% | 23.51% | 23.50% | 23.94% | 25.04% | 27.26% | 31.51% | 100.94% | 98.77% | 102.93% | 102.33% |
| Research & Development | 0.00 | 153.17M | 125.51M | 107.87M | 24.46M | 0.00 | 60.09M | 86.22M | 360.22M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 171.90M | 142.83M | 137.95M | 153.62M | 148.86M | 159.89M | 152.84M | 145.44M | 150.13M | 164.61M | 174.87M | 150.09M | 133.55M | 160.61M | 171.49M | 170.15M | 104.61M | 57.18M | 34.07M |
| Selling & Marketing | 389.91M | 428.67M | 480.27M | 508.18M | 463.65M | 456.59M | 287.17M | 389.99M | 352.36M | 352.53M | 247.06M | 298.36M | 184.83M | 139.08M | 224.66M | 217.57M | 161.95M | 102.15M | 72.82M |
| SG&A | 561.81M | 571.50M | 618.22M | 661.80M | 612.51M | 616.48M | 440.01M | 535.43M | 502.49M | 517.14M | 421.93M | 448.45M | 318.38M | 299.69M | 396.15M | 387.72M | 266.56M | 159.33M | 106.90M |
| Other Expenses | 2.41B | 422.39M | 112.93M | 27.22M | 9.80M | -6.19M | 0.00 | 86.22M | 358.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 2.97B | 1.97B | 1.98B | 1.96B | 2.09B | 2.11B | 1.93B | 1.99B | 1.94B | 1.96B | 1.80B | 1.75B | 1.37B | 941.26M | 1.03B | 6.78B | 6.34B | 4.08B | 2.28B |
| Cost & Expenses | 15.92B | 15.29B | 15.67B | 14.81B | 22.07B | 25.82B | 17.04B | 14.81B | 14.94B | 14.52B | 14.33B | 14.11B | 11.14B | 8.62B | 6.82B | 6.71B | 6.44B | 3.94B | 2.21B |
| Interest Income | 123.90M | 17.26M | 18.83M | 26.82M | 27.02M | 59.59M | 52.21M | 67.90M | 56.31M | 158.42M | 116.26M | 160.40M | 128.93M | 40.00K | 7.30M | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 871.42M | 827.98M | 699.44M | 857.65M | 918.07M | 878.23M | 883.67M | 939.61M | 869.91M | 881.25M | 881.27M | 1.05B | 901.78M | 740.88M | 603.02M | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 607.18M | 591.19M | 569.68M | 602.53M | 607.66M | 632.57M | 643.09M | 622.51M | 573.89M | 765.57M | 841.78M | 759.49M | 607.22M | 460.96M | 387.46M | 303.07M | 194.79M | 115.77M | 83.60M |
| EBITDA | 1.69B | 863.08M | 1.70B | 790.29M | 2.18B | 2.10B | 2.15B | 2.47B | 2.45B | 2.49B | 2.51B | 2.96B | 2.36B | 2.41B | 2.15B | 1.39B | 1.50B | 865.43M | 781.51M |
| EBITDA Ratio | 10.01% | 3.87% | 9.08% | 6.39% | 8.02% | 7.55% | 11.46% | 12.66% | 12.43% | 14.93% | 15.30% | 18.19% | 18.23% | 22.80% | 24.07% | 17.84% | 19.41% | 18.46% | 26.90% |
| Operating Income | 923.81M | -40.98M | 1.02B | 511.30M | 1.61B | 2.03B | 1.74B | 1.64B | 1.83B | 1.69B | 1.66B | 2.20B | 1.77B | 1.95B | 1.65B | 1.09B | 1.31B | 749.66M | 697.91M |
| Operating Income Ratio | 5.49% | -0.27% | 6.14% | 3.31% | 6.81% | 7.31% | 9.26% | 9.97% | 10.90% | 10.27% | 10.16% | 13.52% | 13.57% | 18.43% | 19.49% | 13.95% | 16.89% | 15.99% | 24.02% |
| Total Other Income/Expenses | -741.12M | -383.22M | -683.22M | -1.47B | -1.22B | -1.42B | -1.10B | -950.34M | -1.18B | -1.06B | -881.15M | -994.30M | -1.04B | -731.32M | -482.01M | -446.74M | -480.80M | -218.55M | -241.32M |
| Income Before Tax | 182.69M | -424.20M | 340.80M | -847.67M | 374.71M | 588.20M | 626.83M | 674.17M | 638.25M | 847.54M | 782.28M | 1.15B | 854.32M | 1.20B | 1.15B | 641.63M | 827.52M | 531.11M | 456.59M |
| Income Before Tax Ratio | 1.08% | -2.78% | 2.04% | -5.49% | 1.58% | 2.11% | 3.34% | 4.10% | 3.81% | 5.16% | 4.78% | 7.06% | 6.56% | 11.41% | 13.63% | 8.23% | 10.68% | 11.33% | 15.72% |
| Income Tax Expense | 132.74M | -182.37M | 90.34M | -115.04M | 56.82M | 112.20M | 104.11M | 120.79M | 95.85M | 184.90M | 161.43M | 290.09M | 122.16M | 162.38M | 230.11M | 111.89M | 80.13M | -63.83M | 76.70M |
| Net Income | 49.95M | -241.83M | 250.47M | -732.64M | 317.89M | 476.00M | 522.72M | 553.38M | 542.40M | 662.64M | 620.86M | 857.42M | 732.16M | 1.04B | 922.88M | 529.74M | 747.39M | 467.28M | 379.89M |
| Net Income Ratio | 0.30% | -1.59% | 1.50% | -4.75% | 1.34% | 1.71% | 2.79% | 3.37% | 3.24% | 4.03% | 3.79% | 5.28% | 5.62% | 9.87% | 10.91% | 6.79% | 9.65% | 9.97% | 13.08% |
| EPS | 0.22 | -1.08 | 1.12 | -3.27 | 1.42 | 2.12 | 2.33 | 2.47 | 2.42 | 2.95 | 2.77 | 3.82 | 3.26 | 4.65 | 5.83 | 3.47 | 4.97 | 3.04 | 2.76 |
| EPS Diluted | 0.22 | -1.08 | 1.12 | -3.27 | 1.42 | 2.12 | 2.33 | 2.47 | 2.42 | 2.95 | 2.77 | 3.82 | 3.26 | 4.65 | 4.29 | 2.53 | 3.57 | 2.22 | 2.76 |
| Weighted Avg Shares Out | 227.03M | 224.26M | 224.26M | 224.26M | 224.26M | 224.26M | 224.26M | 224.26M | 224.26M | 224.26M | 224.26M | 224.26M | 224.26M | 224.26M | 159.40M | 152.26M | 149.65M | 148.87M | 137.63M |
| Weighted Avg Shares Out (Dil) | 227.03M | 224.26M | 224.26M | 224.26M | 224.26M | 224.26M | 224.26M | 224.26M | 224.26M | 224.26M | 224.26M | 224.26M | 224.26M | 224.26M | 216.71M | 208.97M | 208.27M | 203.91M | 137.63M |
Source: https://incomestatements.info
Category: Stock Reports